Investing.com - Sophia Genetics reported on Tuesday third quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Sophia Genetics announced earnings per share of $-0.36 on revenue of $11.6M. Analysts polled by Investing.com anticipated EPS of $-0.36 on revenue of $11.45M.
Sophia Genetics shares are down 20% from the beginning of the year and are trading at $2.10 , down-from-52-week-high.
Sophia Genetics shares gained 8.25% in pre-market trade the report.
Sophia Genetics follows other major Healthcare sector earnings this month
Sophia Genetics's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar